ADMA Biologics, Inc.
ADMA
$20.61
$0.974.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 100.86% | 16.92% | 41.16% | -34.51% | -40.65% |
| Total Receivables | 82.34% | 60.10% | -18.02% | 87.12% | 76.85% |
| Inventory | -1.54% | 5.32% | 11.14% | 8.38% | 5.90% |
| Prepaid Expenses | 50.52% | 86.88% | 5.85% | -14.56% | 4.69% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 28.95% | 16.26% | 14.07% | 4.67% | -4.95% |
|
|
|||||
| Total Current Assets | 28.95% | 16.26% | 14.07% | 4.67% | -4.95% |
| Net Property, Plant & Equipment | -0.20% | -3.06% | -4.27% | -4.30% | -7.67% |
| Long-term Investments | 0.00% | 0.01% | 0.01% | 0.01% | 0.00% |
| Goodwill | 0.00% | 0.01% | 0.01% | 0.01% | 0.00% |
| Total Other Intangibles | -7.82% | 1.70% | -26.95% | -61.54% | -50.74% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,825.85% | -13.44% | -16.98% | 24.84% | -2.10% |
| Total Assets | 48.45% | 11.93% | 9.73% | 2.96% | -5.53% |
|
|
|||||
| Total Accounts Payable | 29.11% | 47.63% | 17.33% | 32.64% | 18.38% |
| Total Accrued Expenses | -6.30% | -11.12% | -14.87% | 51.76% | 31.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.56% | 21.38% | 16.59% | 14.33% | 15.47% |
| Total Finance Division Other Current Liabilities | 115.04% | 25.46% | 167.32% | 60.16% | 31.36% |
| Total Other Current Liabilities | 115.04% | 25.46% | 167.32% | 60.16% | 31.36% |
| Total Current Liabilities | 11.52% | 7.29% | 5.30% | 44.54% | 26.84% |
|
|
|||||
| Total Current Liabilities | 11.52% | 7.29% | 5.30% | 44.54% | 26.84% |
| Long-Term Debt | -44.61% | -28.66% | -6.58% | -9.32% | -8.57% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -12.46% | -11.04% | -10.17% | -9.37% | -8.64% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -15.20% | -2.19% | -2.15% | 3.05% | 3.10% |
| Total Liabilities | -28.00% | -19.66% | -4.14% | 1.04% | -1.28% |
|
|
|||||
| Common Stock & APIC | 2.52% | 1.92% | 1.05% | 1.86% | 1.82% |
| Retained Earnings | 39.05% | 13.94% | 7.08% | -0.75% | -5.91% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 158.14% | 53.13% | 28.28% | 5.53% | -11.03% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 158.14% | 53.13% | 28.28% | 5.53% | -11.03% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 158.14% | 53.13% | 28.28% | 5.53% | -11.03% |
|
|
|||||